Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06293703 · ClinicalTrials.gov registry record · NA

Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)

A NA study of Morbid Obesity, sponsored by Salvador Navarrete.

Recruiting
Registry status
NA
Development phase
262
Enrollment target
1
Study location

NCT06293703 is a NA study of Morbid Obesity that is actively recruiting participants, run by Salvador Navarrete. The registered enrollment target is 262 participants, above the 111-participant average among 24 other Morbid Obesity trials with a reported enrollment target (136% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06293703, a NA study of Morbid Obesity, is actively recruiting participants, sponsored by Salvador Navarrete.

RECRUITING
Registry status
NA
Development phase
262 participants
Enrollment target
1
Study location

Study Summary

The investigators propose a randomized controlled trial comparing BP and roux limb lengths measuring 30 and 15% respectively of patient's total small bowel length versus current standard practice using fixed lengths. The findings would provide further insight into feasibility of standardizing RYGB limb lengths and optimizing resultant weight loss and metabolic effects. The investigators hypothesize RYGB with ratio-adjusted limb lengths (aRYGB) will result in higher total weight loss and resolution of metabolic syndrome comorbidities, including diabetes, hyperlipidemia, and hypertension compared to standard fixed-length RYGB (sRYGB). The study will also utilize the Short Form Rand 36-Item Health Survey (SF36) to determine differences in postoperative quality of life metrics.

Conditions Studied

Interventions

  • PROCEDURE Surgery

Study Locations (1)

Ohio

  • Cleveland clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 262 participants
Start Date 2024-01-12
Est. Completion 2030-12-11
Phase NA

Sponsor

Salvador Navarrete

1 total trials

What the Registry Record Tells You About NCT06293703

The ClinicalTrials.gov registry entry for NCT06293703 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 111-participant average among 24 other Morbid Obesity trials with a reported enrollment target (136% higher). The listed sponsor is Salvador Navarrete, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Morbid Obesity appearing as the primary indexed condition, and to 1 intervention - of which Surgery is the first listed.

NCT06293703 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06293703 about?

NCT06293703 is a clinical study titled "Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)". The investigators propose a randomized controlled trial comparing BP and roux limb lengths measuring 30 and 15% respectively of patient's total small bowel length versus current standard practice using fixed lengths. The findings would provide further insight into feasibility of standardizing RYGB l...

What is the current status of trial NCT06293703?

This trial is currently recruiting. It is a NA study. The enrollment target is 262 participants. The study started on 2024-01-12. Estimated completion is 2030-12-11.

What conditions does trial NCT06293703 study?

This clinical trial studies the following conditions: Morbid Obesity.

What interventions are being tested in trial NCT06293703?

The interventions under investigation include: Surgery (PROCEDURE).

Who is sponsoring clinical trial NCT06293703?

This trial is sponsored by Salvador Navarrete, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06293703 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Morbid Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.